Apollo Hospitals Enterprise Limited · NSE:APOLLOHOSP
Apollo Hospitals Enterprise — Q4 FY2012 Earnings Presentation
21 slides from Apollo Hospitals Enterprise's earnings presentation, June 2012
Slide 1: Q4 FY 2012 Earnings Update
Q4 FY 2012 Earnings Update Q4 FY 2012 Earnings Update 1
Slide 2: Safe Harbour
Safe Harbour No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all events not current after the
Slide 3: Contents
Contents • Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational p Performance – Hospitals p • Operational Performance – Standalone Pharmacies • Update on Projects • Update on non-hospital JVs, Associates 3
Slide 4: Highlights – (1/2) Financial Performance
Highlights – (1/2) FY12 Consolidated Revenues of Rs Rs. 31,475 31 475 mio (up 20.8% 20 8% yoy) Financial Performance FY12 Consolidated EBITDA of Rs. 5,131 mio (up 22.5% yoy) FY12 Consolidated EBITDA margin at 16.3% as compared to 16.1% in FY11 C Consolidated lid t d PAT off Rs. R 2,194 2 194
Slide 5: Highlights – (2/2) Capacity
Highlights – (2/2) 50 hospitals with total bed capacity of 8,276 beds as on March 31, 2012 C Capacity it 36 owned hospitals including JVs/ Subsidiaries and associates with 5,888 beds and 14 Managed hospitals with 2,388 beds. Discontinued Management contract with Indore hospital (237 beds). Of
Slide 6: Contents
Contents • Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational p Performance – Hospitals p • Operational Performance – Standalone Pharmacies • Update on Projects • Update on non-hospital JVs, Associates 6
Slide 7: Consolidated Financial Performance
Consolidated Financial Performance ` Mio Q4 Q4 FY 11 FY 12 yoy (%) FY11 FY12 yoy (%) Income from Operations 6,700 8,013 19.6% 24,597 29,530 20.1% Add: Share of JVs 421 559 33 0% 33.0% 1 457 1,457 1 945 1,945 33 5% 33.5% Total Revenues 7,121 8,572 20.4% 26,054 31,475 20.8% EBITDA 1,039 1,309 25.9% 4,
Slide 8: Contents
Contents • Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational p Performance – Hospitals p • Operational Performance – Standalone Pharmacies • Update on Projects • Update on non-hospital JVs, Associates 8
Slide 9: Standalone Financial Performance – (1/2)
Standalone Financial Performance – (1/2) ` Mio Q4 Q4 Key Highlights FY11 FY12 yoy (%) FY 11 FY 12 yoy (%) (FY12) Revenues of Rs. Revenue 6,214 7,446 19.8% 23,320 28,001 20.1% 28,001 mio, 20.1% yoy growth. Operative Expenses 3,315 3,825 15.4% 12,276 14,555 18.6% E l Employee E Expenses 973 1 142 1,
Slide 10: Standalone Segment-wise Performance – (2/2)
Standalone Segment-wise Performance – (2/2) ` Mio Q4 Q4 Key y Highlights g g FY11 FY12 yoy (%) FY 11 FY 12 yoy (%) (FY12) Revenues from each segment Healthcare services Heathcare Services * 4,395 5,070 15.4% 16,712 19,402 16.1% Revenues at Rs. 19,402 mio, 16.1% yoy Stand-alone Pharmacy 1,821 2,377
Slide 11: Contents
Contents • Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational p Performance – Hospitals p • Operational Performance – Standalone Pharmacies • Update on Projects • Update on non-hospital JVs, Associates 11
Slide 12: Operational Performance – Hospitals
Operational Performance – Hospitals ` Mio Total (5) Chennai cluster Hyderabad cluster Others (1) Significant subs/ JVs/ associates (2) Particulars FY 11 FY 12 Growth FY 11 FY 12 Growth FY 11 FY 12 Growth FY 11 FY 12 Growth FY 11 FY 12 Growth yoy (%) yoy (%) yoy (%) yoy (%) yoy (%) No. of Operating b
Slide 13: Contents
Contents • Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational p Performance – Hospitals p • Operational Performance – Standalone Pharmacies • Update on Projects • Update on non-hospital JVs, Associates 13
Slide 14: Operational Performance – Standalone Pharmacy
Operational Performance – Standalone Pharmacy ` Mio Q4 Q4 Batch Particulars FY11 FY12 yoy % FY 11 FY 12 yoy % No of Stores 314 298 314 298 Upto FY Revenue/store 2.2 2.5 13.0% 8.40 9.60 14.3% 2007 EBITDA /store 0.1 0.1 20.5% 0.43 0.54 25.5% Batch EBITDA Margin % 5.4% 5.8% 36 bps 5.2% 5.7% 50 bps No o
Slide 15: Contents
Contents • Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational p Performance – Hospitals p • Operational Performance – Standalone Pharmacies • Update on Projects • Update on non-hospital JVs, Associates 15
Slide 16: Key Hospital Expansion Plan & Update on Execution
Key Hospital Expansion Plan & Update on Execution Total Estim ated AHEL's Project Share of Type of Cost Cost Location CoD* Hospital No of Beds (Rs.m io) (Rs.m io) Focus on owned hospitals Mumbai Cluster No. of owned hospitals to increase to over 50 from Navi Mumbai FY14 Super Specialty 350 3,500 3
Slide 17: Contents
Contents • Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational p Performance - Hospitals p • Operational Performance - Standalone Pharmacies • Update on Projects • Update on non-hospital JVs, Associates 17
Slide 18: Update on non hospital JVs, Associates
Update on non hospital JVs, Associates ` Mio Particulars FY 11 FY 12 yoy (%) Y-O-Y revenue growth of 9.7%. Expansion in EBITDA margins by 554 bps at 17.2% in FY12 as compared to 11.6% in FY11. Total Income 4,476 4,909 9.7% FY12 PAT had one off litigation g costs of approximately Rs. 101 mio an
Slide 19: Q&A
Q&A 19
Slide 20: Appendix: Basis of Consolidation
Appendix: Basis of Consolidation AHEL Standalone Location Description Chennai Main Chennai Hospital ASH - Chennai Chennai Hospital Tondiarpet - Chennai Chennai Hospital FirstMed - Chennai Chennai Hospital Apollo Children's Hospital Chennai Hospital Madurai Madurai Hospital Karur Karur Hospital Karai
Slide 21: Hospitals – Understanding Key Operating Metrics
Hospitals – Understanding Key Operating Metrics Description p Formula / Calculation Key y Driver Number of operating - Project execution Operating Beds beds Capital Expenditure x In-patient Bed Days In-patient Bed Days Brand Occupancy Billed Doctor reputation Quality of outcomes
Apollo Hospitals Enterprise — Q4 FY2012 Earnings Presentation on 6ix